THE FIX

Firm Event | September.18.2025 | 10am - 10pm (British Summer Time (GMT +01:00))

Harwell Science and Innovation Campus, Oxford

Join us and the VOYAGERS team, a global community of impact-driven professionals and health tech specialists, at this year’s THE FIX festival.

This full-day event brings together thought leaders, industry experts, and key decision-makers to address the sector’s most pressing challenges and explore how we can shape the future of health technology.

The program includes:

  • Workshops, product demonstrations, and expert-led sessions
  • Participant-driven “unconference” discussions
  • Startup pitch competition and speed networking opportunities
  • Tours of the Harwell Science Campus

Throughout the day, select Orrick U.S. partners will also lead a workshop exploring healthtech regulation, strategies for expanding internationally, and approaches to fundraising within the sector.

For more details on speakers, agenda, and partners, and to register with a 20% discount using the following code ORRICK20, please click below.

453876

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Georgia C. Ravitz 合伙人

Washington, D.C.

Georgia also has extensive experience in assisting clients with product recalls, crisis management and government enforcement. Her practice in this sector includes assisting manufacturers, distributors, retailers and importers on all types of FDA regulated products including pharmaceuticals, medical devices and software, wearables, health and wellness products, cosmetics, cell and plant based foods, conventional foods, ag tech, compounded drugs, and dietary supplements.

Georgia’s deep experience and ability to provide practical guidance in FDA and FDA-adjacent regulatory matters allows her to work closely with innovative companies looking to minimize regulatory burdens and maximize U.S. marketing opportunities in the life science and health tech industry verticals. She also conducts regulatory due diligence for private equity and public company transactions involving life science, medtech and innovative companies.

Georgia is a frequent speaker at conferences and events who contributes regularly to leading trade and consumer media outlets.

453686

Practice:

  • FDA & Healthcare Regulatory
  • Life Sciences & HealthTech
  • Strategic Advisory & Government Enforcement (SAGE)
  • Technology Companies Group
  • Technology & Innovation

Amy M. Joseph 合伙人

Boston

Amy works with digital health companies, health systems and other public and private companies—from new entrants to seasoned organizations—to address regulatory compliance and transactional needs. She also advises investors and collaborates with clients to understand their business goals and tailor practical solutions to help them achieve those objectives. Amy is well-versed in the corporate governance, data privacy, and security and scope-of-practice considerations facing the healthcare industry as it incorporates artificial intelligence (AI) and machine-learning (ML) solutions into clinical workflows. Her practice includes structuring and scaling national telehealth practices across a range of clinical disciplines, including complex collaborative arrangements involving labs, medical device manufacturers, remote patient monitoring solutions and pharmacies.

Amy spends much of her time working with clients on vetting and developing strategic affiliations, joint venture transactions and other novel business arrangements, including developing value-based enterprises and otherwise identifying means to achieve further alignment among stakeholders. She advises on reimbursement issues with respect to federal healthcare programs, private payors and self-pay business models. She also helps develop compliance programs and advises on related protocols and best practices.

In particular, Amy advises on physician self-referral, anti-kickback and other fraud and abuse law matters as well as on patient privacy matters, including HIPAA, 42 CFR Part 2 and corresponding state-level compliance. Amy also assists with internal investigations and assessing and responding to the results, including developing corrective action recommendations and self-disclosures.

A sought-after speaker and prolific writer on some of the most complex and critical issues in healthcare law, Amy shares her insights in publications and presentations across the country. She co-authored chapters in numerous publications, including the telemedicine chapter of the American Bar Association’s Physician Law: Evolving Trends & Hot Topics and a chapter addressing telehealth in the MCLE Massachusetts Health and Hospital Law Manual.

Chambers USA notes that Amy has “deep expertise in matters that impact healthcare providers and healthcare transactions,” “is a terrific resource on a range of regulatory issues” and “an expert in the Stark Law.”

Amy graduated first in her class at UCLA Law and was elected to the Order of the Coif. Prior to law school, Amy served in the U.S. Air Force.

350459

Practice:

  • Technology & Innovation
  • Technology Companies Group
  • Mergers & Acquisitions
  • Fintech
  • Israel
  • Life Sciences & HealthTech
  • Private Equity
  • 战略咨询
  • UK

Ylan Steiner 合伙人

伦敦

Following an earlier career as a computer software programmer, Ylan has a passion for technology and innovation across numerous sectors.

Ylan’s notable company-side representations include Currencycloud, EVRYTHNG, Griffin Financial, MFS Africa, nPlan, Railsbank, Signal AI and Taster. One CEO client described Ylan as the “most incredible lawyer… [who I have worked with] for years. He's that good and his deal team is good too.”

In addition to his company-side representations, Ylan acts for leading venture capital and private equity firms and other strategic investors, including Vitruvian Partners, Warburg Pincus, Kennet Capital Partners, Kinnevik, Marlin Equity Partners, Seedcamp, and Oxx.

Ylan has been consistently recognised as a leading venture capital advisor in both Legal 500 and Chambers and Partners. Ylan was described by one client in Legal 500 UK 2022 as “an exceptionally knowledgeable counsel – he helped guide me through a number of challenges around our fundraise with ease, speed and clarity.”

A recent career highlight for Ylan was being invited by HM Treasury to advise on the UK Government’s Future Fund in response to calls from the technology industry to support VC backed start-ups throughout the ongoing COVID-19 pandemic.

Practice:

  • Finance Sector
  • Mergers & Acquisitions
  • Technology Companies Group
  • Real Estate
  • Energy

Katie Cotton 合伙人

伦敦

She represents clients in the technology, Internet, digital media and marketing, artificial intelligence, fintech, e-commerce and hardware and software industries, and also represents clients in the energy & infrastructure, consumer products, hospitality and financial services sectors.

Katie's experience includes public and private mergers and acquisitions, earn-outs, carve-outs, asset acquisitions and disposals, recapitalisations, management buy-outs and take-private transactions, joint ventures, strategic alliances and minority investments. She has extensive experience with cross-border transactions and is particularly well-known for acting on sales of venture-backed companies to major international trade and financial buyers.